CLOZAPINE VS. OTHER ANTIPSYCHOTICS FOR SCHIZOPHRENIA AND CO-OCCURRING CANNABIS USE DISORDER

被引：0
|
作者：
Brunette, Mary [1 ]
Dawson, R. [2 ]
O'Keefe, C. D. [1 ]
Noordsy, D. L. [1 ]
Green, Alan [1 ]
机构：
[1] Dartmouth Med Sch, Dept Psychiat, Hanover, NH USA
[2] Frontier Sci Res & Technol, Boston, MA USA
来源：
SCHIZOPHRENIA BULLETIN | 2011年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：297 / 297
页数：1
相关论文
共 50 条
  • [41] Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation
    Whitfield-Gabrieli, Susan
    Fischer, Adina S.
    Henricks, Angela M.
    Khokhar, Jibran Y.
    Roth, Robert M.
    Brunette, Mary F.
    Green, Alan I.
    SCHIZOPHRENIA RESEARCH, 2018, 194 : 70 - 77
  • [42] METABOLIC SYNDROME IN PATIENTS WITH SCHIZOPHRENIA: POLYPHARMACY WITH FIRST GENERATION ANTIPSYCHOTICS VS. CLOZAPINE ALONE
    Softic, R.
    Avdibegovic, E.
    Sutovic, A.
    Becirovic, E.
    Osmanovic, E.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [43] Clinical correlates of co-occurring cannabis and tobacco use: a systematic review
    Peters, Erica N.
    Budney, Alan J.
    Carroll, Kathleen M.
    ADDICTION, 2012, 107 (08) : 1404 - 1417
  • [44] TREATMENT OF ADOLESCENTS WITH CO-OCCURRING MENTAL HEALTH AND CANNABIS USE DISORDERS
    Riggs, Paula
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10): : S128 - S128
  • [45] Pharmacological Treatment of Schizophrenia and Co-Occurring Substance Use Disorders
    David A. Smelson
    Lisa Dixon
    Thomas Craig
    Stephen Remolina
    Steven L. Batki
    Noosha Niv
    Richard Owen
    CNS Drugs, 2008, 22 : 903 - 916
  • [46] Cognition and emotion-based decision-making in patients with schizophrenia and co-occurring cannabis use disorders
    Sevy, Serge
    Burdick, K.
    Lukin, M.
    Abdelmessih, S.
    Riojas, I.
    Yechiam, E.
    Bechara, A.
    AMERICAN JOURNAL ON ADDICTIONS, 2007, 16 (04): : 318 - 319
  • [47] Pharmacological Treatment of Schizophrenia and Co-Occurring Substance Use Disorders
    Smelson, David A.
    Dixon, Lisa
    Craig, Thomas
    Remolina, Stephen
    Batki, Steven L.
    Niv, Noosha
    Owen, Richard
    CNS DRUGS, 2008, 22 (11) : 903 - 916
  • [48] Metacognitive Reflection and Insight Therapy for Schizophrenia: Case Study of a Patient With a Co-Occurring Substance Use Disorder
    James, Alison V.
    Leonhardt, Bethany L.
    Buck, Kelly D.
    AMERICAN JOURNAL OF PSYCHOTHERAPY, 2018, 71 (04) : 155 - 163
  • [49] Behavioral predictors of alcohol drinking in a neurodevelopmental rat model of schizophrenia and co-occurring alcohol use disorder
    Khokhar, Jibran Y.
    Todd, Travis P.
    SCHIZOPHRENIA RESEARCH, 2018, 194 : 91 - 97
  • [50] Gender differences in psychosis with co-occurring substance use disorder
    Martinez Riera, R.
    Mateu Codina, G.
    Castillo Buenaventura, C.
    Hurtado Ruiz, M. G.
    Marti Bonany, J.
    Sanchez Gonzalez, R.
    Torrens Melich, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S567 - S567
12345